BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,000 | -99.3% | 10 | -99.4% | 0.00% | -100.0% |
| Q4 2020 | $152,000 | +744.4% | 1,778 | +295.1% | 0.02% | +700.0% |
| Q3 2019 | $18,000 | -30.8% | 450 | -25.0% | 0.00% | -33.3% |
| Q2 2019 | $26,000 | -66.2% | 600 | -71.0% | 0.00% | -40.0% |
| Q3 2018 | $77,000 | -7.2% | 2,066 | -2.3% | 0.01% | -16.7% |
| Q2 2018 | $83,000 | – | 2,114 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 857,494 | $55,746,000 | 45.68% |
| RP Management, LLC | 2,111,111 | $137,243,000 | 20.57% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,074,800 | $134,883,000 | 17.78% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,310,261 | $85,180,000 | 9.56% |
| TANG CAPITAL MANAGEMENT LLC | 599,091 | $38,947,000 | 7.05% |
| Blackcrane Capital, LLC | 44,112 | $2,868,000 | 6.69% |
| ARS Investment Partners, LLC | 559,574 | $36,378,000 | 5.72% |
| Eversept Partners, LP | 321,581 | $20,905,981 | 4.64% |
| Avidity Partners Management LP | 1,284,200 | $83,486,000 | 3.87% |
| ARDSLEY ADVISORY PARTNERS LP | 257,000 | $16,708,000 | 3.22% |